Complement 2: Blood Donations to Develop Vaccines Against Infectious Diseases

Inclusion Criteria: * Willing and able to give informed consent for participation in the study * Aged between 18 and 70 years * In good health as determined by medical history and clinical judgment of the Investigators * Able to attend the scheduled visits and to comply with all study procedures * If found to be a suitable complement that they are willing to be approached for further donations Exclusion Criteria: * Body weight less than 50kgs * Have any known or suspected impairment or alteration of immune function, resulting from, as examples:congenital or acquired immunodeficiency, receipt of immunosuppressive therapy such as anti-cancer chemotherapy or radiation therapy within the preceding 12 months or long-term systemic corticosteroid therapy, receipt of immunoglobulin or any blood product transfusion within the last 3 months * Female participants who are pregnant * Any chronic illness that could, in the opinion of the Investigators, interfere with immune function or with the donation of large volumes of blood (e.g. thrombocytopaenia or coagulopathy, malabsorption disorders, chronic anaemia) * An individual who is on the delegation log for the study * Planned blood donation within 4 months of undergoing testing to assess whether the individual is a suitable Complement donor